Think Tanks

Think Tanks
Accessed 02 Apr 2022
The economic case for federal investment in COVID-19 vaccines and therapeutics remains strong
Susan Athey, Rena M. Conti, Matthew Fiedler, Richard G. Frank, and Jonathan Gruber
Friday, April 1, 2022
Center for Global Development [to 02 Apr 2022]
Publications, Events [Selected]
Reexamining Global Health: Global Commons, Financing Priorities, and the Role of Institutions in the Global South
The COVID-19 pandemic has showcased the large vulnerabilities of the global health architecture and weaknesses in the resilience of national health systems. It has also reinvigorated a debate about the right way to prioritize and use development assistance for health (DAH).
YouTube Recording:
Chatham House [to 02 Apr 2022]
Accessed 02 Apr 2022
Pandemic: Needled by the rulebook
At last, there is a new proposal for a waiver on Covid-19 vaccine patents, but it is a far from useful compromise, says James Love
The World Today 1 April 2022
James Love, Director of Knowledge Ecology International

Accessed 02 Apr 2022
[No new digest content identified]


Kaiser Family Foundation
Accessed 02 Apr 2022
March 28, 2022 News Release
Many Uninsured People Could Lose Access to Free COVID-19 Testing, Treatment, and Vaccines as Federal Funding Runs Out
With an impasse in Congress over additional COVID-19 emergency funding, uninsured people could lose access to free testing and treatment services, a new KFF brief explains. For people without health insurance, the Health Resources and Services Administration (HRSA) COVID-19 Uninsured Program has reimbursed hospitals, doctors and other providers for the…
Rand [to 02 Apr 2022]
Reports, Selected Journal Articles
Understanding Competition: Great Power Rivalry in a Changing International Order — Concepts and Theories
U.S. national security policy for the foreseeable future will likely be oriented around competition with China and Russia. The author reviews U.S. government strategy, RAND research, and other sources to help explain international competitions.
Mar 30, 2022
Michael J. Mazarr